Literature DB >> 779443

Pathobiologic features of human candidiasis. A common deep mycosis of the brain, heart and kidney in the altered host.

J C Parker, J J McCloskey, K A Knauer.   

Abstract

In a review of 2,616 consecutive autopsies done at the University of Kentucky Medical Center over a 12-year period, 46 patients with complete postmortem examinations had tissue-verified candidiasis in two distinct patterns, with Candida albicans being most frequently cultured. Superficial candidiasis involving only lining surfaces was observed in 21 patients (46%). Usually, it complicated other lethal problems such as malignancy and bacterial sepsis. Nineteen of these patients (95%) had received antibiotics. No vessel invasion or deep organ involvement was evident in this group. The other pattern of candidiasis was a deep or systemic variety recognized in the remaining 25 patients (54%). It was characterized by deep parenchymal organ lesions usually involving the brain (52%), heart (48%), and kidney (80%), but any tissue seemed susceptible. Vessel invasion was seen in 8 patients (32%); intravenous lines were used in 13 (52%); and major operations were done in 16 (64%). All these patients were hospitalized for either benign or malignant conditions and were treated for bacterial sepsis with antibiotics for seven days or more. This investigation indicates that candidiasis occurs when the host's environment is altered primarily by antibiotic therapy. Candida then can colonize lining surfaces and from there could invade adjacent vessels and disseminate throughout the body.

Entities:  

Mesh:

Year:  1976        PMID: 779443     DOI: 10.1093/ajcp/65.6.991

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  28 in total

Review 1.  Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Authors:  Mary Ann Jabra-Rizk; Eric F Kong; Christina Tsui; M Hong Nguyen; Cornelius J Clancy; Paul L Fidel; Mairi Noverr
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 2.  Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis.

Authors:  Sarah E W Grubb; Craig Murdoch; Peter E Sudbery; Stephen P Saville; Jose L Lopez-Ribot; Martin H Thornhill
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

Review 3.  Candida and invasive candidiasis: back to basics.

Authors:  C S-Y Lim; R Rosli; H F Seow; P P Chong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-05       Impact factor: 3.267

4.  High-frequency switching in Candida strains isolated from vaginitis patients.

Authors:  D R Soll; C J Langtimm; J McDowell; J Hicks; R Galask
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

5.  Presumptive identification of Candida kefyr on levine formulation of eosin methylene blue agar.

Authors:  Erik L Munson; Dennis R Troy; Joanne K Weber; Shawn A Messer; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 6.  Organ-specific mechanisms linking innate and adaptive antifungal immunity.

Authors:  Rebecca A Drummond; Michail S Lionakis
Journal:  Semin Cell Dev Biol       Date:  2018-02-01       Impact factor: 7.727

7.  Biochemical examination of sera during systemic Candida infection in mice.

Authors:  D Oblack; J Schwarz; I A Holder
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

8.  Evaluation of enzyme-linked immunosorbent assays for detecting circulating antibodies to Candida albicans.

Authors:  Harry E Prince; Cindy Yeh; Navid Alem; Mandana Asalkhou; Nina Hamedi; Neda Alem; Mehdi Alem
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

9.  Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B.

Authors:  J S Solomkin; A Flohr; R L Simmons
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

10.  Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model.

Authors:  Donna M MacCallum
Journal:  FEMS Yeast Res       Date:  2009-10       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.